Meditor Group Ltd 13D and 13G filings for Esperion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-03 11:02 am Sale |
2023-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
Meditor Group Ltd | 3,791,300 3.300% |
-677,535 (-15.16%) |
Filing |
| 2023-01-04 2:30 pm Unchanged |
2022-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
Meditor Group Ltd | 4,468,835 6.100% |
0 (Unchanged) |
Filing |
| 2022-01-12 2:15 pm Purchase |
2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
Meditor Group Ltd | 4,468,835 7.100% |
1,789,000 (+66.76%) |
Filing |
| 2021-01-06 2:37 pm Unchanged |
2020-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
Meditor Group Ltd | 2,679,835 9.600% |
0 (Unchanged) |
Filing |